保誠與AlipayHK、醫思健康及11 SKIES等5間企業合組戰略聯盟
保誠(02378.HK)宣布,與10Life、AlipayHK、醫思健康(02138.HK)、安心三寶及11 SKIES達成全新戰略合作關係,大力擴充其覆蓋財富、健康及一系列保障方案的生態系統。
保誠保險香港行政總裁林智剛表示,透過與這些夥伴合作,公司得以為客戶提供頂尖全面的體驗及不同優惠,標誌著保誠發展其生態系統策略的重要里程碑。
隨著這五個全新戰略合作夥伴的加盟,並聯同現有的20多個夥伴,保誠將進一步強化其全面的夥伴合作生態系統。這生態系統覆蓋多個主要消費者接觸點,橫跨個人護理及醫療保健、酒店、零售、健身及教育的不同範疇,同時提供財富傳承和財富管理服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.